Amarin (ADR) (AMRN)
Commercializes icosapent ethyl for cardiovascular care through Vascepa and Vazkepa.
$13.75
After hours−0.08 (−0.58%)
At close$13.83(+2.60%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$0.10
Revenue estimate
$43.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported−$2.40−$0.04−$0.03$0.01$0.01−$0.09−$0.02Pending
Estimate−$0.40−$1.12−$0.66$0.08$0.07$0.01−$0.01−$0.10
Surprise−500.0%+96.4%+95.5%−87.5%−85.7%−1,000.0%−100.0%—
RevenueReportedEstimate
Mar '25May '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported$62.3M$41.0M$72.7M$49.7M$49.2M$45.1M$42.2MPending
Estimate$36.0M$50.7M$53.8M$43.1M$50.6M$43.8M$44.6M$43.8M
Surprise+73.3%−19.1%+35.3%+15.2%−2.8%+3.1%−5.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2027 | −$0.02 | — | — |
| Mar 2027 | −$0.01 | — | — |
| Dec 2026 | −$0.05 | — | — |
| Nov 2026 | −$0.10 | — | — |
| Jul 2026 | −$0.01 | −$0.02 | −100.0% |
| Apr 2026 | $0.01 | −$0.09 | −1,000.0% |
| Feb 2026 | $0.07 | $0.01 | −85.7% |
| Oct 2025 | $0.08 | $0.01 | −87.5% |
| Jul 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 2027 | −$0.02 | — | — | $39.9M | — | — | — |
| Mar 2027 | −$0.01 | — | — | $41.9M | — | — | — |
| Dec 2026 | −$0.05 | — | — | $46.7M | — | — | — |
| Nov 4, 2026 | −$0.10 | — | — | $43.8M | — | — | — |
| Jul 29, 2026 | −$0.01 | −$0.02 | −100.0% | $44.6M | $42.2M | −5.3% | +1.5% |
| Apr 29, 2026 | $0.01 | −$0.09 | −1,000.0% | $43.8M | $45.1M | +3.1% | +2.4% |
| Feb 25, 2026 | $0.07 | $0.01 | −85.7% | $50.6M | $49.2M | −2.8% | −9.5% |
| Oct 29, 2025 | $0.08 | $0.01 | −87.5% | $43.1M | $49.7M | +15.2% | −11.3% |
| Jul 30, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 12, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 3, 2023 | |||||||
| Mar 1, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 5, 2021 | |||||||
| Apr 29, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 4, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Jul 31, 2019 | |||||||
| May 1, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 2, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 1, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 3, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Nov 4, 2015 | |||||||
| Aug 6, 2015 |